These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10678488)

  • 1. Evaluation and prediction of drug permeation.
    Pagliara A; Reist M; Geinoz S; Carrupt PA; Testa B
    J Pharm Pharmacol; 1999 Dec; 51(12):1339-57. PubMed ID: 10678488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in computational prediction of drug absorption and permeability in drug discovery.
    Hou T; Wang J; Zhang W; Wang W; Xu X
    Curr Med Chem; 2006; 13(22):2653-67. PubMed ID: 17017917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug permeation in biomembranes: in vitro and in silico prediction and influence of physicochemical properties.
    Mälkiä A; Murtomäki L; Urtti A; Kontturi K
    Eur J Pharm Sci; 2004 Sep; 23(1):13-47. PubMed ID: 15324921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical predictions of drug absorption in drug discovery and development.
    Stenberg P; Bergström CA; Luthman K; Artursson P
    Clin Pharmacokinet; 2002; 41(11):877-99. PubMed ID: 12190333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling of drug disposition kinetics in in vitro intestinal absorption cell models.
    Heikkinen AT; Korjamo T; Mönkkönen J
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):180-8. PubMed ID: 20030630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption.
    Yu LX; Lipka E; Crison JR; Amidon GL
    Adv Drug Deliv Rev; 1996 Jun; 19(3):359-76. PubMed ID: 11540095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic enhancement of the intestinal absorption of drugs containing the polar guanidino functionality.
    Sun J; Miller JM; Beig A; Rozen L; Amidon GL; Dahan A
    Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):313-23. PubMed ID: 21235283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of physicochemical and pharmacokinetic parameters in lead optimization: a physiological pharmacokinetic model based approach.
    Benjamin B; Barman TK; Chaira T; Paliwal JK
    Curr Drug Discov Technol; 2010 Sep; 7(3):143-53. PubMed ID: 20843296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
    Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
    Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional intestinal drug permeation: biopharmaceutics and drug development.
    Lennernäs H
    Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
    Lin X; Skolnik S; Chen X; Wang J
    Drug Metab Dispos; 2011 Feb; 39(2):265-74. PubMed ID: 21051535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans.
    Hurst S; Loi CM; Brodfuehrer J; El-Kattan A
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):469-89. PubMed ID: 17696800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug dissolution: significance of physicochemical properties and physiological conditions.
    Jambhekar SS; Breen PJ
    Drug Discov Today; 2013 Dec; 18(23-24):1173-84. PubMed ID: 24042023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput pKa screening and prediction amenable for ADME profiling.
    Wan H; Ulander J
    Expert Opin Drug Metab Toxicol; 2006 Feb; 2(1):139-55. PubMed ID: 16863474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms.
    Siepmann J; Siepmann F; Florence AT
    Int J Pharm; 2006 May; 314(2):101-19. PubMed ID: 16647231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational prediction of formulation strategies for beyond-rule-of-5 compounds.
    Bergström CAS; Charman WN; Porter CJH
    Adv Drug Deliv Rev; 2016 Jun; 101():6-21. PubMed ID: 26928657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When poor solubility becomes an issue: from early stage to proof of concept.
    Stegemann S; Leveiller F; Franchi D; de Jong H; Lindén H
    Eur J Pharm Sci; 2007 Aug; 31(5):249-61. PubMed ID: 17616376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug permeability profiling using cell-free permeation tools: Overview and applications.
    Berben P; Bauer-Brandl A; Brandl M; Faller B; Flaten GE; Jacobsen AC; Brouwers J; Augustijns P
    Eur J Pharm Sci; 2018 Jul; 119():219-233. PubMed ID: 29660464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.